ALADIN and its Protein Interactions with the Nucleoproteins: An Insilico Analysis

Authors

  • A. Sharma
  • M. Khurana
  • R. Kaur

DOI:

https://doi.org/10.37591/rrjocb.v7i1.315

Abstract

The nuclear pore complex (NPCs) are big, protein complexes made up of multiple units that traverse the nuclear envelope (NE), establishing a discerning channel between the cytoplasm and nucleus for the nucleocytoplasmic transport. It has different roles in cellular processes, like cell-cycle progression, control of gene expression, and signal transduction. NPC is a vast and complex structure, compiled from almost 30 proteins, termed nucleoporins. Earlier studies have shown that each nucleoporins has an exclusive role in controlling NPC function and the nucleocytoplasmic transport of proteins and RNAs. ALADIN also referred to as adracalin is a nucleoporin is associated with a genetically heritable human disease known as Triple A syndrome. But many mutant ALADIN studies have showed that defect is functional rather than structural, so further suggesting an intricate protein interaction network among several hundred individual components of this ordered assembly of huge complex. In this study, insilico tools have been used to predict the protein-protein interactions of ALADIN protein with other nucleoporins.

 

Keywords: Nucleoporin, mutant, signal transduction, protein interactions, WD-repeats

Cite this Article

A. Sharma, M. Khurana, R. Kaur. Aladin and its Protein Interactions with the Nucleoproteins: An Insilico Analysis. Research & Reviews: Journal of Computational Biology. 2018; 7(1):       28–31p.

Downloads

Published

2018-06-28

Issue

Vol. 7 No. 1 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.